Author:
Maffione Anna Margherita,Giammarile Francesco,Rubello Domenico
Publisher
Springer Science and Business Media LLC
Subject
Radiology, Nuclear Medicine and imaging,General Medicine,Radiology, Nuclear Medicine and imaging,General Medicine
Reference17 articles.
1. Yamaga LYI, Cunha ML, Campos Neto GC, Garcia MRT, Yang JH, Comacho CP, et al. 68Ga- DOTATATE PET/CT in recurrent medullary thyroid carcinoma: a lesion-by-lesion comparison with 111In-octreotide SPECT/CT and conventional imaging. Eur J Nucl Med Mol Imaging. 2017 (in press).
2. Pelizzo MR, Torresan F, Boschin IM, Nacamulli D, Pennelli G, Rubello D, et al. Early, prophylactic thyroidectomy in hereditary medullary thyroid carcinoma: a 26-year monoinstitutional experience. Am J Clin Oncol. 2015;38:508–13.
3. Quayle FJ, Moley JF. Medullary thyroid carcinoma: management of lymph node metastases. Curr Treat Options in Oncol. 2005;6:347–54.
4. Zatelli MC, Tagliati F, Taylor JE, Rossi R, Culler MD, Degli Uberti EC. Somatostatin receptor subtypes 2 and 5 differentially affect proliferation in vitro of the human medullary thyroid carcinoma cell line. J Clin Endocrinol Metab. 2001;86:2161–9.
5. Lynn MD, Shapiro B, Sisson JC, Beierwaltes WH, Meyers LJ, Ackerman R, et al. Pheochromocytoma and the normal adrenal medulla: improved visualization with I-123 MIBG scintigraphy. Radiology. 1985;155:789–92.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献